SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Newron Pharma ...Very attractive CNS-Pipeline
ELN
|
|
|
Newron Pharma (NRWN.SW) Listed on Swiss Exchange
M-Cap : 99,97 Mio CHF ( 88,26 Mio US$ )
Cash : 62,38 Mio CHF ( 55,07 Mio US$ )
Price : 16 CHF
Shares Out : 6,03 Mio
Pipeline
http://www.newron.com/uploads/pipeline_111November3.pdf
Safinamide Significantly Improved Motor Function in Patients with
Advanced Parkinson's Disease in a Phase III Pivotal Trial
<> <>http://www.newron.com/uploads/SAfinamidePIIIresultsNew...
|
Newron Pharma ...Very attractive CNS-Pipeline
ELN
|
|
|
Newron Pharma (NRWN.SW) Listed on Swiss Exchange
M-Cap : 99,97 Mio CHF ( 88,26 Mio US$ )
Cash : 62,38 Mio CHF ( 55,07 Mio US$ )
Price : 16 CHF
Shares Out : 6,03 Mio
Pipeline
http://www.newron.com/uploads/pipeline_111November3.pdf
Safinamide Significantly Improved Motor Function in Patients with
Advanced Parkinson's Disease in a Phase III Pivotal Trial
<> <>http://www.newron.com/uploads/SAfinamidePIIIresultsNew...
|
ELN
ELN
Biogen Reports Another PML Case in Tysabri Patient
ELN
|
|
|
<> 
After the market close, Biogen (BIIB) filed an 8-K with the SEC reporting a new case of the potentially fatal brain disease known as PML or progressive multifocal leukoencephalopathy in a patient receiving their multiple sclerosis [MS] drug Tysabri, adding to the two new cases which were reported previously in July. Biogen is currently trading down by about 15% after hours while marketing partner Elan (ELN) is down by about 25% as of 5:15 PM. The news adds more uncertainty to Tysabri, which was removed from th...
|
Biogen Reports Another PML Case in Tysabri Patient
ELN
|
|
|
<>
After the market close, Biogen (BIIB) filed an 8-K with the SEC reporting a new case of the potentially fatal brain disease known as PML or progressive multifocal leukoencephalopathy in a patient receiving their multiple sclerosis [MS] drug Tysabri, adding to the two new cases which were reported previously in July. Biogen is currently trading down by about 15% after hours while marketing partner Elan (ELN) is down by about 25% as of 5:15 PM. The news adds more uncertainty to Tysabri, which was removed from th...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
|
|
|
|
tanumoy
(+117.03% risk: conservative)
|
|
|
More Resources
|
About Elan Corp plc
- Answers.com
